Fmr LLC lowered its position in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 9.4% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 39,984,116 shares of the biopharmaceutical company’s stock after selling 4,126,249 shares during the period. Fmr LLC owned […]
StockNews.com initiated coverage on shares of Royalty Pharma (NASDAQ:RPRX – Free Report) in a research report sent to investors on Thursday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Other analysts have also issued research reports about the stock. TheStreet upgraded shares of Royalty Pharma from a d+ rating to a c […]
Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) CFO Terrance P. Coyne sold 37,500 shares of the firm’s stock in a transaction on Wednesday, August 9th. The stock was sold at an average price of $30.72, for a total transaction of $1,152,000.00. Following the completion of the sale, the chief financial officer now owns 827,500 […]
Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) has been given a consensus rating of “Buy” by the four ratings firms that are presently covering the firm, Marketbeat reports. Four investment analysts have rated the stock with a buy rating. The average 12 month price target among analysts that have covered the stock in the […]
Envestnet Asset Management Inc. boosted its position in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 22.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,825 shares of the biopharmaceutical company’s stock after buying an additional 2,899 shares during the period. Envestnet […]